All Articles

Healis Therapeutics gets FDA nod for Tyemvers, a botulinum toxin therapy for depression. Can a drug that paralyzes frown muscles disrupt mental healthcare?

Newly-listed GoldInxs is wasting no time, using its $1.54M IPO to fund an advanced 3D survey on a BC property with 'Blackwater-style' potential.

A new initiative by mode40 and CME aims to de-risk AI adoption for Prairie aerospace firms, building a sovereign, data-driven model for the future.

With an accounting-first approach and a new CEO, Asset Vantage is set to tackle the growing complexity facing family offices in the new era of AI wealthtech.

Following an $11B valuation, AI inference leader SambaNova hires a veteran dealmaker to accelerate its push into the high-stakes government and sovereign AI markets.

With a string of major projects and a new wealth channel, Energea's hire of a turnaround expert signals a calculated move to scale its global platform.

The Department of War taps AI startup Kaizen to build a rapid procurement platform, signaling a major shift in how the U.S. counters asymmetric drone warfare.

Edge AI has moved from the lab to the real world. A look at how ZEDEDA is helping giants in shipping and auto make it a global infrastructure reality.

Inside the new Louisville hub where automation and an 'end-of-runway' strategy with UPS aim to redefine speed and precision in drug delivery.

Six months of job growth from small firms paint a picture of resilience, but a closer look reveals a split reality, with healthcare booming and hospitality cooling.

As JUNGSAEMMOOL enters Sephora, it's not just another K-Beauty launch. It's a calculated move signaling a market shift toward professional artistry.

Amid a truck market slump, Core Molding Technologies reveals a strategic shift, leveraging new ventures in energy storage and a major expansion in Mexico.

Saint Agatha Foundation's record grant, born from personal loss, is bringing advanced diagnostic and surgical technology to rural New York, tackling a critical gap.

With a 3.2 million worker shortage looming, a new investment in online trainer ACT reveals how private equity plans to scale a tech-driven solution.

Biotech beauty firm NULASTIN partners with a top PR agency to push its patented elastin science, aiming to dethrone collagen in the anti-aging market.

HSBC Continental Europe's profits fell 88% after a €300M loss on its Malta sale, but a closer look reveals a deliberate pivot toward a leaner future.

With $15B in deals, Volta is treating AI compute like electricity, aiming to build a new utility for an industry constrained by capital, not just chips.

Connected Manufacturing's new AI agents promise to bring order to the factory floor. But is it just tech hype? A look at how governed AI solves compliance.

GE Appliances is doubling its bet on Texas Instruments' US-made chips, a move to de-risk its supply chain and power a new era of ultra-efficient, smart appliances.

As Spokane burns, a local bootmaker shows what it means to stand with your community, turning its brand promise into a lifeline for first responders.